The TPX2 gene is a promising diagnostic and therapeutic target for cervical cancer

Author：            

Publisher： Spandidos Publications

ISSN： 1021-335X

Source： Oncology Reports, Vol.27, Iss.5, 2012-01, pp. : 1353-1359

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Histones and lung cancer: are the histone deacetylases a promising therapeutic target?

By Petta Vasiliki   Gkiozos Ioannis   Strimpakos Alex   Syrigos Konstantinos  

Cancer Chemotherapy and Pharmacology, Vol. 72, Iss. 5, 2013-11 ,pp. : 935-952

Springer Publishing Company

Access to resources Recommend Favorite

BMI1, a promising therapeutic target for human cancer (Review)

By Wang MinCong   Li ChunLi   Cui Jie   Jiao Min   Wu Tao   Jing Li   Nan KeJun  

Oncology Letters, Vol. 10, Iss. 2, 2015-08 ,pp. : 583-588

Spandidos Publications

Access to resources Recommend Favorite

LPTS: A Novel Tumor Suppressor Gene and a Promising Drug Target for Cancer Intervention

By  

Recent Patents on Anti-Cancer Drug Discovery, Vol. 10, Iss. 2, 2015-05 ,pp. : 170-175

Bentham Science Publishers

Access to resources Recommend Favorite

TPX2 regulates tumor growth in human cervical carcinoma cells

By            

Molecular Medicine Reports, Vol. 9, Iss. 6, 2014-01 ,pp. : 2347-2351

Spandidos Publications

Access to resources Recommend Favorite

Telomerase and Cancer: A Promising Target

By Maria Laura Falchetti  

American Journal of Cancer, Vol. 3, Iss. 1, 2004-01 ,pp. : 1-11

Adis International

Access to resources Recommend Favorite